PCI No Riskier With Plavix Plus Statins, CCBs (CME/CE)
(MedPage Today) -- Patients undergoing percutaneous coronary intervention did not have an increased risk of cardiovascular events if they received clopidogrel against a background of statin or calcium channel blocker therapy, a large clinical trial showed.
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news
More News: Angioplasty | Calcium | Cardiology | Cardiovascular | Cholesterol | Clinical Trials | Clopidogrel | Coronary Angioplasty | Heart | Percutaneous Coronary Intervention | Plavix | Statin Therapy